A gene variant in the cannabinoid receptor influenced how THC affected brain attention signals | Research

The takeaway

A specific repeat polymorphism in the CNR1 cannabinoid receptor gene modulated how THC affected the P300 brain wave, a marker of attention and working memory.

Read this if you are interested in why people respond differently to cannabis and what role genetics plays.

CNR1 genotype predicted sensitivity to THC effects on attention

What the researchers found

Twenty healthy volunteers received oral THC, cannabis extract (THC + CBD), or placebo in a controlled study. Both THC and cannabis extract reduced P300 amplitudes (a brain wave associated with attention and working memory), with no difference between the two cannabinoid conditions.

However, when participants were grouped by their CNR1 gene variant (an AAT repeat polymorphism), those with the >10/>10 genotype showed a significant P300 amplitude decrease and latency prolongation specifically under pure THC, but not under cannabis extract containing both THC and CBD.

The number of AAT repeats correlated with P300 changes under THC, suggesting the cannabinoid receptor gene directly influenced sensitivity to THC's cognitive effects.

Why it matters

This was early evidence that genetic variation in the cannabinoid receptor gene could explain why people respond differently to cannabis. The finding that CBD in the extract appeared to buffer the genetic sensitivity to pure THC was also notable.

The numbers in context

20 healthy volunteers. CNR1 (AAT)n repeat polymorphism genotyped. >10/>10 genotype showed significant P300 changes under THC but not cannabis extract. Number of AAT repeats correlated with THC-induced P300 changes.

How the study worked

Study of 20 healthy volunteers genotyped for the CNR1 (AAT)n polymorphism. Participants received oral THC, cannabis extract (THC + CBD), or placebo. EEG P300 was recorded during an auditory choice reaction task.

What this study cannot tell us

Very small sample size (20 volunteers) limits genetic analysis power. A single genetic variant was examined. The study could not determine whether the genotype effect has real-world cognitive consequences beyond EEG changes.

How to read the evidence

Small RCT with genetic subgroup analysis. Exploratory pharmacogenomic study with interesting findings but insufficient sample size for definitive conclusions.

When this study was published

Published in 2011. Cannabis pharmacogenomics has expanded but remains an early-stage field.

The bigger picture

The same CNR1 polymorphism had been associated with both schizophrenia and substance dependence. This study connected those genetic findings to a specific cognitive mechanism, potentially explaining why some individuals are more vulnerable to cannabis-related cognitive effects and psychosis risk.

Questions still open

Does the CNR1 polymorphism predict real-world cognitive impairment from cannabis? Could genetic testing identify individuals at higher risk for adverse cannabis effects? Does CBD genuinely protect against genotype-specific THC sensitivity?

Common questions

Can your genes determine how cannabis affects you?

This study found that a specific variant in the cannabinoid receptor gene (CNR1) influenced how THC affected attention-related brain waves. People with certain versions of this gene showed more pronounced cognitive effects from pure THC.

Did CBD make a difference based on genetics?

People with the sensitive genotype showed significant P300 changes under pure THC but not under cannabis extract containing both THC and CBD. This suggested CBD may buffer the genetic sensitivity, though the sample was too small to be definitive.

Read the original research

Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.

Neuroscience letters, 496(1), 60-4

View on PubMed ↗Publisher’s paper ↗

Citation

Stadelmann, Andreas M; Juckel, Georg; Arning, Larissa; Gallinat, Jürgen; Epplen, Jörg T; Roser, Patrik. (2011). Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.. Neuroscience letters, 496(1), 60-4. https://doi.org/10.1016/j.neulet.2011.04.003